2025
SJR Q2
JCR Q4 · 1,6
2 eşleşen makale
SCIE
Dergi ayrıntısı
Pharmacogenetics and Genomics
- Yayıncı
- Lippincott Williams and Wilkins
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1744687217446880
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,498
- Quartile Q2
- H-Index 158
- Atıf/yayın 1,9
- Doküman (3y) 103
- Atıf (3y) 192
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,6
- 5Y JIF 1,8
- JCI 0,43
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Genetics Q3
- Genetics (clinical) Q3
- Molecular Biology Q3
- Molecular Medicine Q3
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous) Q2
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Biotechnology & Applied Microbiology | Genetics & Heredity | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q4 | 0,498 | 1,6 | 1,8 | 0,43 | Q3 | 158 |
| 2024 | Q2 | Q3 | 0,553 | 1,7 | 1,8 | 0,49 | Q3 | 154 |
| 2023 | Q1 | Q3 | 0,563 | 1,7 | 1,8 | 0,57 | Q3 | 154 |
| 2022 | Q1 | Q3 | 0,486 | 2,6 | 2,6 | 0,57 | Q3 | 154 |
| 2021 | Q2 | Q4 | 0,385 | 2 | 2,8 | 0,51 | Q3 | 154 |
| 2020 | Q2 | Q4 | 0,579 | 2,1 | 3 | 0,76 | Q2 | 154 |
| 2019 | Q3 | Q2 | 0,774 | 2,9 | 2,6 | 0,85 | Q2 | 154 |
| 2018 | — | Q2 | — | 2,7 | 2,8 | 0,82 | Q2 | — |
| 2017 | Q2 | Q2 | 0,933 | 2,2 | 2,8 | 0,78 | Q2 | 154 |
| 2016 | Q2 | Q2 | 1,009 | 2,2 | 3,1 | — | — | 154 |
| 2015 | Q2 | Q2 | 1,254 | 2,9 | 3,2 | — | — | 154 |
| 2014 | Q2 | Q1 | 1,343 | 3,5 | 3,6 | — | — | 154 |
| 2013 | Q2 | Q1 | 1,317 | 3,5 | 3,7 | — | — | 154 |
| 2012 | Q2 | Q1 | 1,23 | 3,6 | 3,9 | — | — | 154 |
| 2011 | Q2 | Q1 | 1,315 | 3,5 | 4 | — | — | 154 |
| 2010 | Q2 | Q1 | 1,479 | 3,9 | 4,6 | — | — | 154 |
| 2009 | — | Q1 | — | 4 | 4,8 | — | — | — |
| 2008 | — | Q1 | — | 4,4 | 5,3 | — | — | — |
| 2007 | — | Q1 | — | 5,8 | 5,8 | — | — | — |
| 2006 | — | Q1 | — | 5,4 | — | — | — | — |
| 2005 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 155/180 |
| 2025 | GENETICS & HEREDITY | SCIE | Q4 | Q3 | 151/192 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 276/356 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q3 | 138/177 |
| 2024 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 135/192 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 256/352 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q3 | 138/174 |
| 2023 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 138/191 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 251/354 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | Q3 | 108/158 |
| 2022 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 101/171 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 183/278 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q3 | 137/159 |
| 2021 | GENETICS & HEREDITY | SCIE | Q4 | Q3 | 145/175 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 233/279 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q2 | 126/159 |
| 2020 | GENETICS & HEREDITY | SCIE | Q4 | Q2 | 134/176 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q2 | 217/276 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 68/156 |
| 2019 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 86/178 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 116/271 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 66/162 |
| 2018 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 81/174 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 126/267 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 80/161 |
| 2017 | GENETICS & HEREDITY | SCIE | Q3 | Q2 | 101/171 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 152/261 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 78/160 |
| 2016 | GENETICS & HEREDITY | SCIE | Q3 | — | 100/167 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 152/257 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 52/161 |
| 2015 | GENETICS & HEREDITY | SCIE | Q2 | — | 70/166 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 87/255 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 36/163 |
| 2014 | GENETICS & HEREDITY | SCIE | Q2 | — | 52/167 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 61/255 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 39/165 |
| 2013 | GENETICS & HEREDITY | SCIE | Q2 | — | 56/165 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 56/256 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 33/160 |
| 2012 | GENETICS & HEREDITY | SCIE | Q2 | — | 51/161 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 52/261 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 37/158 |
| 2011 | GENETICS & HEREDITY | SCIE | Q2 | — | 49/158 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 57/261 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 30/160 |
| 2010 | GENETICS & HEREDITY | SCIE | Q2 | — | 44/156 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 45/252 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 26/152 |
| 2009 | GENETICS & HEREDITY | SCIE | Q1 | — | 35/146 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 38/237 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 19/144 |
| 2008 | GENETICS & HEREDITY | SCIE | Q1 | — | 25/138 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 26/219 |
| 2007 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 9/138 |
| 2007 | GENETICS & HEREDITY | SCIE | Q1 | — | 18/132 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 13/205 |
| 2006 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 12/140 |
| 2006 | GENETICS & HEREDITY | SCIE | Q1 | — | 21/131 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 16/199 |
| 2005 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | — | — | — |
| 2005 | GENETICS & HEREDITY | SCIE | — | — | — |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | — | — | — |